Literature DB >> 1483074

Gangliosides and neurological diseases.

P O Behan, B A Haniffah.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1483074      PMCID： PMC1883871          DOI： 10.1136/bmj.305.6865.1309

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  8 in total

Review 1.  Critical review of gangliosides and thyrotropin-releasing hormone in peripheral neuromuscular diseases.

Authors:  W G Bradley
Journal:  Muscle Nerve       Date:  1990-09       Impact factor: 3.217

2.  Recovery from experimental parkinsonism in primates with GM1 ganglioside treatment.

Authors:  J S Schneider; A Pope; K Simpson; J Taggart; M G Smith; L DiStefano
Journal:  Science       Date:  1992-05-08       Impact factor: 47.728

3.  Bovine gangliosides and acute motor polyneuropathy.

Authors:  A Figueras; F J Morales-Olivas; D Capellà; V Palop; J R Laporte
Journal:  BMJ       Date:  1992-11-28

4.  Ganglioside abnormalities in multiple sclerosis.

Authors:  R K Yu; R W Ledeen; L F Eng
Journal:  J Neurochem       Date:  1974-07       Impact factor: 5.372

5.  Recovery of motor function after spinal-cord injury--a randomized, placebo-controlled trial with GM-1 ganglioside.

Authors:  F H Geisler; F C Dorsey; W P Coleman
Journal:  N Engl J Med       Date:  1991-06-27       Impact factor: 91.245

Review 6.  Toward a unified theory of ganglioside-mediated functional restoration after brain injury: lesion size, not lesion site, is the primary factor determining efficacy.

Authors:  J J Ramirez; B A Sabel
Journal:  Acta Neurobiol Exp (Wars)       Date:  1990       Impact factor: 1.579

7.  GM1 ganglioside treatment reduces visual deficits after graded crush of the rat optic nerve.

Authors:  J Sautter; M Schwartz; R Duvdevani; B A Sabel
Journal:  Brain Res       Date:  1991-11-22       Impact factor: 3.252

8.  Acute motor neuropathy with antibodies to GM1 ganglioside.

Authors:  N A Gregson; D Jones; P K Thomas; H J Willison
Journal:  J Neurol       Date:  1991-12       Impact factor: 4.849
  8 in total
  7 in total

1.  Gangliosides and neurological diseases.

Authors:  G Doria; G Tettamanti
Journal:  BMJ       Date:  1993-01-16

2.  Gangliosides in neurological diseases.

Authors:  A G García; J Berciano; J F Horga; S López-Pousa; J M Martínez-Lage; J Matias-Guiu
Journal:  BMJ       Date:  1993-03-06

3.  Gangliosides and neurological diseases.

Authors:  J S Schneider; D P Roeltgen
Journal:  BMJ       Date:  1993-01-16

4.  Gangliosides in neurological diseases.

Authors:  C J Gibbs; G M McKhann; F S Walsh; R K Yu
Journal:  BMJ       Date:  1993-03-06

Review 5.  [Brain gangliosides and memory formation].

Authors:  H Rahmann
Journal:  Naturwissenschaften       Date:  1994-01

6.  The Therapeutic Role of Gangliosides in Neurological Disorders.

Authors:  J S Schneider
Journal:  CNS Drugs       Date:  1994-03       Impact factor: 5.749

Review 7.  Gangliosides. Their role in clinical neurology.

Authors:  E Nobile-Orazio; M Carpo; G Scarlato
Journal:  Drugs       Date:  1994-04       Impact factor: 9.546
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.